logo

For the Inventor, By the Inventor

Seoul, South Korea

Hong-Sig Sin

This inventor holds 3 USPTO granted patents. Top assignees: Chebigen Inc., Chebigen Co., Ltd.. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong-Sig Sin. Retrieved from https://idiyas.com/inventor/hong-sig-sin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

% Patents Active = 33.3

Average Co-Inventor Count = 9.7

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Seoul, KR (2006 - 2007)
  • Jeonju-si, KR (2012)

Company Filing History:

goldMedal2 out of 2 
 
Chebigen Inc.
 patents
silverMedal1 out of 1 
 
Chebigen Co., Ltd.
 patent

Years Active: 2006-2012

Loading Chart...
3 patents (USPTO):Explore Patents
1. 8282961 - Method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule (2012-10-09),
2. 7166744 - Retinoid derivatives and methods for producing said compounds and anti-cancer pharmaceutical composition comprising said compounds (2007-01-23),
3. 7030265 - Retinol derivatives, the method of preparations and the uses thereof (2006-04-18),

Title: Innovations of Hong-Sig Sin

Introduction

Hong-Sig Sin is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of microencapsulation and pharmaceutical compositions. With a total of 3 patents, his work focuses on innovative methods that enhance the stability and efficacy of various compounds.

Latest Patents

One of his latest patents is a method of preparing a microcapsule containing unsaturated fatty acids. This invention outlines a process that includes preparing a first coating material by mixing and gelatinating specific gums with poly glycerin esters of fatty acid in sterilized water. The method also involves adding unsaturated fatty acid to the solution and homogenizing it. Additionally, he has developed a novel retinoid derivative compound that exhibits high anti-cancer effects without causing undesirable side effects. This compound is part of an anti-cancer pharmaceutical composition, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Hong-Sig Sin has worked with companies such as Chebigen Inc. and Chebigen Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects.

Collaborations

Some of his notable coworkers include Si-Ho Park and Soo-Jong Um. Their collaboration has likely fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Hong-Sig Sin's contributions to the fields of microencapsulation and pharmaceuticals highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a deep understanding of complex scientific principles and a commitment to advancing technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…